Journal of Clinical & Experimental Pathology
Open 91桃色
Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open 91桃色 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open 91桃色 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Citations : 2975
Indexed In
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Open J Gate
- Genamics JournalSeek
- JournalTOCs
- Cosmos IF
- Ulrich's Periodicals Directory
- RefSeek
- Directory of Research Journal Indexing (DRJI)
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- ICMJE
- world cat
- journal seek genamics
- j-gate
- esji (eurasian scientific journal index)
Useful Links
Recommended Journals
Related Subjects
Share This Page
Biomarkers in cancer immunotherapy
Joint Event on 6th World Congress and Expo on Breast Pathology and Cancer Diagnosis & 20th International Conference on Medicinal Chemistry and Rational Drugs
Paola Ferrari
University Hospital of Pisa, Italy
Keynote: J Clin Exp Pathol
DOI:
Abstract
Immunotherapy has gained increasing consent in different types of advanced and/or metastatic cancer. More recently, checkpoint inhibitors have been extensively studied and in some cases they have been approved by regulatory authorities for cancer therapy. However, only a minority of patients exhibits a durable response to immunotherapy, while toxicity and costs of these treatments are not insignificant. In this view, biomarkers predicting response, resistance and toxicity should be important for a better selection of patients. PD-L1 expression, TIL identification and characterisation, mutation load, microsatellite instability, MDSCs, IDO, IFN-gamma/Jak pathway mutations are some of these markers. Due to the complexity of immune response, the identification of reliable markers is difficult and research is in progress.Biography
Paola Ferrari graduated in Medicine and Surgery at Pisa University in 1995 (full marks), specialized in Internal Medicine in 2000, PhD in Medical Physiopathology and Pharmacology. She works as medical oncologist at Unit of Oncology 1, Department of Oncology, New Technologies and Transplantations, University of Pisa. Clinical activity: Follow-up and therapy of cancer patients, mainly breast cancer patients. Principal fields of research: Breast and gastrointestinal cancer follow-up and therapy, breast cancer biomarkers and prognostic factors, cancer immunology, circulating tumor cells, cancer stem cells. Paola Ferrari is author/co-author of about 50 articles in peer reviewed journals. She regularly serves as reviewer for international oncology journals.
E-mail: paolaferrari226@libero.it
